HLF Herbalife beats by $0.23, beats on revs; guides Q3 EPS below consensus, revs in-line; guides FY13 EPS above consensus, revs above consensus (60.57 +2.12)Reports Q2 (Jun) earnings of $1.41 per share, $0.23better than the Capital IQ Consensus Estimate of $1.18; revenues rose 18.2% year/year to $1.22 bln vs the $1.16 bln consensus.
Co issues mixed guidance for Q3,sees EPS of 1.09-1.13 vs. $1.16 Capital IQ Consensus Estimate; sees Q3 revs growth of 11.5-13.5% (Approx $1.13- 1.15 bln) vs. $1.15 bln Capital IQ Consensus Estimate. Sees Volume Point Growth in the range of 11.4-13.5%; Net Sales Growth 16.5-18.5%; CapEx in the range of $40-50 mln.
Co issues upside EPS guidance for FY13, sees EPS of $4.83-4.95 vs. $4.80 Capital IQ Consensus Estimate; sees FY13 revs between 16.0-18.0% (approx $4.72-4.80 bln) vs. $4.63 bln Capital IQ Consensus Estimate. sees Volume Point Growth between 11.5-13.5%; Expects net sales growth in the range of 16-18%; Sees CapEx in the range of $165-185 mln.
$HLF up to $63.20 at the time of this post.